Trial intelligence / Profile preview

Levocetirizine for Nasal Obstruction in Perennial Allergic Rhinitis

NCT00439712Phase 4Completed

Sponsor
Institut für Atemwegsforschung
Start
Feb 2007
Primary completion
May 2007
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of levocetirizine in perennial allergic rhinitis (PAR), sponsored by Institut für Atemwegsforschung. Started Feb 2007; status: completed.

02

Drugs

levocetirizine
03

Conditions

perennial allergic rhinitis (PAR)

Beyond the preview

Go deeper on NCT00439712.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00439712.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call